Mercer Global Advisors
RGC icon

Mercer Global Advisors’s Regencell Bioscience RGC Stock Holding History

Mercer Global Advisors’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91 Buy
+15
New +$360 ﹤0.01% 5975

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mercer Global Advisors's RGC Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Regencell Bioscience (RGC) in Q2 2026: 15 shares worth $91. The stake represents ﹤0.01% of the portfolio and ranks #5975 among its holdings.

15 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • Mercer Global Advisors held 15 shares of Regencell Bioscience worth $91 as of Q2 2026.
  • Regencell Bioscience was a new Mercer Global Advisors position in Q2 2026.
  • Regencell Bioscience made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5975 holding.
  • 15 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.